Some are thinking that their legal strategy is paying off:
Lawyers on both sides agree that Merck’s victories, and its stated strategy of trying every case rather than settling any, are discouraging plaintiffs with weaker claims. Already, lawyers for plaintiffs have recently withdrawn more than 300 federal suits, mainly after finding that their clients could not produce adequate evidence that they took the drug.
